Yang Shuangshuang, He Tong, Sun Jide, Sun Shan
Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People's Republic of China.
Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, People's Republic of China.
Infect Drug Resist. 2019 Sep 18;12:2971-2978. doi: 10.2147/IDR.S216926. eCollection 2019.
Co-evolution of host and aeromonads has diversified their spectrums of diseases and antibiograms, while a paucity of data was concerning about this diversity in China. To fill this gap, this study was aimed to investigate and compare antimicrobial resistance (AMR) patterns of clinically important spp. from various clinical sources.
A multicenter retrospective surveillance study was conducted in Chongqing from 2011 to 2017. Data of strains were retrieved from the database of China Antimicrobial Resistance Surveillance System (CARSS). Whonet 5.6 and Graphpad Prism 6 Software were adopted to determine and compare distribution and AMR patterns.
Among 1135 strains, complex (65.6%, 745/1135) was the most predominant species, followed by complex (16.7%, 190/1135) and complex (15.3%, 174/1135). Sputum was the most frequent source of strains (27.7%), followed by wound (20.8%), bloodstream (10.8%) and urine (8.8%). Urinary strains demonstrated the highest resistance rates to ceftriaxone (65.6%), ceftazidime (52.1%), cefepime (38.3%), ciprofloxacin (47.7%) and trimethoprim-sulfamethoxazole (56.6%). Similar AMR pattern was observed in intestinal strains, with corresponding resistance rates of 29.4%, 28.9%, 22.2%, 27.3% and 45%, respectively. However, respiratory, bloodstream and skin strains exhibited resistance rates of less than 20% to most of the antimicrobials tested. In terms of species, approximately 30% of complex and complex strains were resistant to ceftriaxone and trimethoprim-sulfamethoxazole, while complex strains harbored resistance rates of less than 20% to all tested antimicrobials. Although antibiograms of these species were distinct, they remained constant from 2011 to 2017.
Distinct AMR patterns between species and sources highlighted the predominance of complex and high resistance of strains in urine and intestine to extended-spectrum cephalosporins, ciprofloxacin and trimethoprim-sulfamethoxazole in Southwest China. Temporally constant AMR patterns should not relax the vigilance of antimicrobial resistance in clinically important species.
宿主与气单胞菌的共同进化使其疾病谱和抗菌谱多样化,而中国关于这种多样性的数据却很匮乏。为填补这一空白,本研究旨在调查和比较来自各种临床来源的重要菌种的抗菌药物耐药性(AMR)模式。
2011年至2017年在重庆进行了一项多中心回顾性监测研究。菌株数据从中国抗菌药物耐药性监测系统(CARSS)数据库中检索。采用Whonet 5.6和Graphpad Prism 6软件来确定和比较分布及AMR模式。
在1135株菌株中,嗜水气单胞菌复合群(65.6%,745/1135)是最主要的菌种,其次是温和气单胞菌复合群(16.7%,190/1135)和豚鼠气单胞菌复合群(15.3%,174/1135)。痰液是最常见的菌株来源(27.7%),其次是伤口(20.8%)、血液(10.8%)和尿液(8.8%)。尿液菌株对头孢曲松(65.6%)、头孢他啶(52.1%)、头孢吡肟(38.3%)、环丙沙星(47.7%)和复方磺胺甲恶唑(56.6%)的耐药率最高。肠道菌株也观察到类似的AMR模式,相应的耐药率分别为29.4%、28.9%、22.2%、27.3%和45%。然而,呼吸道、血液和皮肤菌株对大多数测试抗菌药物的耐药率低于20%。就菌种而言,约30%的嗜水气单胞菌复合群和温和气单胞菌复合群菌株对头孢曲松和复方磺胺甲恶唑耐药,而豚鼠气单胞菌复合群菌株对所有测试抗菌药物的耐药率均低于20%。尽管这些菌种的抗菌谱不同,但在2011年至2017年期间保持不变。
菌种和来源之间不同的AMR模式突出了嗜水气单胞菌复合群的优势以及西南地区尿液和肠道中菌株对广谱头孢菌素、环丙沙星和复方磺胺甲恶唑的高耐药性。AMR模式在时间上保持不变不应放松对临床重要菌种抗菌药物耐药性的警惕。